Preferential Autoimmune Response in Prostate Cancer to Cyclin B1 in a Panel of Tumor-Associated Antigens

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Blood autoantibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancer

(2014) Hongda Chen et al.   CANCER LETTERS

Systematic review: Serum autoantibodies in the early detection of gastric cancer

(2014) Simone Werner et al.   INTERNATIONAL JOURNAL OF CANCER

Androgen Receptor Promotes the Oncogenic Function of Overexpressed Jagged1 in Prostate Cancer by Enhancing Cyclin B1 Expression via Akt Phosphorylation

(2014) Yongjiang Yu et al.   MOLECULAR CANCER RESEARCH

Prostate-specific antigen screening: A critical review of current research and guidelines

(2014) James G. Robinson et al.   Journal of the American Association of Nurse Practitioners

Serologic Autoantibodies as Diagnostic Cancer Biomarkers--A Review

(2013) P. Zaenker et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison

(2012) Chad R. Ritch et al.   BJU INTERNATIONAL

A genetic variant of FcγRIIIa is strongly associatedwith humoral immunity to cyclin B1 in African American patients with prostate cancer

(2012) Janardan P. Pandey et al.   IMMUNOGENETICS

Identification of cyclin B1 and Sec62 as biomarkers for recurrence in patients with HBV-related hepatocellular carcinoma after surgical resection

(2012) Li Weng et al.   Molecular Cancer

Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53

(2011) Diego F. Calvisi et al.   HEPATOLOGY

Influence of Publication of US and European Prostate Cancer Screening Trials on PSA Testing Practices

(2011) S. B. Zeliadt et al.   JNCI-Journal of the National Cancer Institute

A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases

(2011) Chong Xie et al.   Journal of Translational Medicine

Obese African-Americans with prostate cancer (T1c and a prostate-specific antigen, PSA, level of

(2010) Arthur A. Caire et al.   BJU INTERNATIONAL

The Myc-Nucleophosmin-ARF network: A complex web unveiled

(2010) Zhaoliang Li et al.   CELL CYCLE

Evaluation of cell cycle protein expression in gastric cancer: cyclin B1 expression and its prognostic implication

(2010) Maria D. Begnami et al.   HUMAN PATHOLOGY

Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer

(2010) Ganna Chornokur et al.   PROSTATE

The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men

(2009) Stephen Culp et al.   BJU INTERNATIONAL

High cyclin B1 expression is associated with poor survival in breast cancer

(2009) K Aaltonen et al.   BRITISH JOURNAL OF CANCER

Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma

(2009) Yao Chen et al.   CANCER LETTERS

Modes of p53 Regulation

(2009) Jan-Philipp Kruse et al.   CELL

Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohort

(2009) E. Niméus-Malmström et al.   INTERNATIONAL JOURNAL OF CANCER

Autoantibodies to tumor-associated antigens: reporters from the immune system

(2008) Eng M. Tan et al.   IMMUNOLOGICAL REVIEWS